Replies to post #687 on Vascular Biogenics Ltd (VBLT)

[gr8db8]

Even though avastin is not effective for OS, it is the SOC for rGBM. Hopefully, VB-111 shows that it is more effective, and displaces it as the SOC for rGBM. This will pave the way for VB-111 to be considered for other types of cancers, and potential frontline combo treatment for GBM.